Sara Isbell has an extensive background in neuroscience, with specific training and expertise in neurodegenerative diseases and conditions, including a recently published paper in drug design and development in Dove Medical Press. Over the course of her 22-year career as she developed novel experiments and consistently contributed to cutting-edge research. This experience was integral to […]
Amanda has been an integral part of our close-knit team for more than 14 years. Her years of industry and academic experience have helped her gain a comprehensive understanding of important concepts and techniques relevant to our research. Her educational experience from her undergraduate and master’s programs includes an emphasis on neurobiology, oncology, and stem […]
Prior to joining Enabled Therapeutics, Victoria served in Global Medical Affairs, Clinical Development and Research and Discovery with Raptor Pharmaceuticals (acquired by Horizon Pharma). Victoria holds a BS in Biochemistry from the University of the Pacific, an MS in Management with a concentration in Project Management and has an MBA.
Sheana has been with Enabled Therapeutics since it was founded in 2017. She has been instrumental in creating processes and structure for the Laboratory and the Organization as a whole. Sheana has spent the last four years in the Laboratory at the bench conducting experiments, serving as the Health and Safety Officer, avidly participating in […]
Ms. Tsuchimoto co-founded Mercaptor Discoveries Inc. and is our part-time Chief Financial Officer. Ms. Tsuchimoto is also the Chief Financial Officer of Monopar Therapeutics since June 2015. Ms. Tsuchimoto has spent over nine years at Raptor Pharmaceuticals, as its Chief Financial Officer from Raptor’s inception in May 2006 until August 2012, as Raptor’s Vice President […]
Annie is the consummate caregiver of the team. She handles finance, benefits, accounting and the wide array of day-to-day operations that make this place run seamlessly. Annie is detail-oriented yet doesn’t sweat the small stuff. She supports the entire Enabled Therapeutics team, facilitating our research and helping to build a strong infrastructure and foundation for […]
Dr. Zankel co-founded and seed-funded Enabled Therapeutics in 2016. He is also the company’s chief science officer (CSO). Dr. Zankel began his career in drug-development as the fourth employee of BioMarin Pharmaceutical, in 1997, completing his tenure there as Senior Director of Research in 2005. He then co-founded Raptor Pharmaceuticals, in 2006, acting as CSO […]
